Abstract
We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (P=0.0361 and P=0.0237, respectively). Copyright © 2013, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Miyashita, N., Akaike, H., Teranishi, H., Ouchi, K., & Okimoto, N. (2013). Macrolide-resistant mycoplasma pneumoniae pneumonia in adolescents and adults: Clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrobial Agents and Chemotherapy, 57(10), 5181–5185. https://doi.org/10.1128/AAC.00737-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.